17 Nov 2018 | 11:53 PM
Research Report
Daily

Equity Research Report: Religare Morning Digest

We feel the recent consolidation is healthy for markets and it would rebound further in near future. Maintain focus on stock selection.
09 Nov 2018 | 07:00 AM

  • Voltas reported its Q2FY19 numbers wherein Net sales grew by 37.1% yoy to Rs. 1,421 cr. EBITDA came in at 154.6 cr, up by 13% yoy. Lower growth in EBITDA was on account of lower than expected margins in the room AC segment. Net profit was up by 9.3% to  Rs. 103.5 cr.
  • Sanghi Industries reported its Q2FY19 numbers wherein Net sales grew by 18.7% yoy to Rs. 244 cr. However, net profit was down sharply by 82.1% to  Rs. 2 cr mainly on account of contraction in operating margin for the company.
  • Suven Life Sciences Ltd announced the grant of one  product patent from Israel and one product patent from Japan corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents which are valid through 2036 and 2034 respectively.